Humana Inc. Files Definitive Proxy Statement

Ticker: HUM · Form: DEF 14A · Filed: Mar 8, 2024 · CIK: 49071

Humana Inc DEF 14A Filing Summary
FieldDetail
CompanyHumana Inc (HUM)
Form TypeDEF 14A
Filed DateMar 8, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$20.00, $26.09, $2.0 billion, $73 million
Sentimentneutral

Sentiment: neutral

Topics: Proxy Statement, DEF 14A, Humana Inc., SEC Filing, Shareholder Information

TL;DR

<b>Humana Inc. has filed its Definitive Proxy Statement for the upcoming reporting period.</b>

AI Summary

HUMANA INC (HUM) filed a Proxy Statement (DEF 14A) with the SEC on March 8, 2024. Humana Inc. filed a Definitive Proxy Statement (DEF 14A) on March 8, 2024. The filing covers the period ending April 18, 2024. The company's fiscal year ends on December 31. Humana Inc. is incorporated in Delaware. The company's principal executive offices are located at 500 W Main St, Louisville, KY.

Why It Matters

For investors and stakeholders tracking HUMANA INC, this filing contains several important signals. This filing is a standard regulatory requirement for publicly traded companies, providing shareholders with information for upcoming meetings and votes. The DEF 14A filing details executive compensation, board of directors, and other governance matters, which are crucial for shareholder decision-making.

Risk Assessment

Risk Level: low — HUMANA INC shows low risk based on this filing. The filing is a routine DEF 14A, indicating no immediate material events or significant changes requiring a higher risk assessment.

Analyst Insight

Review the proxy statement for details on executive compensation, board nominations, and any shareholder proposals to understand governance and potential strategic directions.

Key Numbers

  • 2024-04-18 — Reporting Period End (Conformed Period of Report)
  • 2024-03-08 — Filing Date (Filed as of Date)
  • 1231 — Fiscal Year End (Fiscal Year End)
  • 610647538 — IRS Number (IRS Number)

Key Players & Entities

  • HUMANA INC (company) — Registrant
  • DEF 14A (document) — Form Type
  • 2024-03-08T00:00:00.000Z (date) — Filed Date
  • 0000049071 (company) — Central Index Key
  • 6324 (industry) — Standard Industrial Classification
  • DE (location) — State of Incorporation
  • 1231 (date) — Fiscal Year End
  • 500 W MAIN ST (address) — Business Address Street 1

FAQ

When did HUMANA INC file this DEF 14A?

HUMANA INC filed this Proxy Statement (DEF 14A) with the SEC on March 8, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by HUMANA INC (HUM).

Where can I read the original DEF 14A filing from HUMANA INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HUMANA INC.

What are the key takeaways from HUMANA INC's DEF 14A?

HUMANA INC filed this DEF 14A on March 8, 2024. Key takeaways: Humana Inc. filed a Definitive Proxy Statement (DEF 14A) on March 8, 2024.. The filing covers the period ending April 18, 2024.. The company's fiscal year ends on December 31..

Is HUMANA INC a risky investment based on this filing?

Based on this DEF 14A, HUMANA INC presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating no immediate material events or significant changes requiring a higher risk assessment.

What should investors do after reading HUMANA INC's DEF 14A?

Review the proxy statement for details on executive compensation, board nominations, and any shareholder proposals to understand governance and potential strategic directions. The overall sentiment from this filing is neutral.

How does HUMANA INC compare to its industry peers?

Humana Inc. operates in the Hospital & Medical Service Plans industry, providing health insurance and related services.

Are there regulatory concerns for HUMANA INC?

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

Industry Context

Humana Inc. operates in the Hospital & Medical Service Plans industry, providing health insurance and related services.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

What Investors Should Do

  1. Review the detailed executive compensation packages outlined in the proxy statement.
  2. Examine the proposed director nominees and any shareholder proposals for insights into corporate governance.
  3. Note the filing date and reporting period to track the company's compliance timeline.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard annual disclosure. No specific comparison to a prior filing's content is available from this excerpt.

Filing Stats: 4,383 words · 18 min read · ~15 pages · Grade level 14.1 · Accepted 2024-03-08 07:31:21

Key Financial Figures

  • $20.00 — uted earnings per common share (EPS) of $20.00 on a Generally Accepted Accounting Prin
  • $26.09 — ciples (GAAP) basis and Adjusted EPS of $26.09. * Returned approximately $2.0 billio
  • $2.0 billion — S of $26.09. * Returned approximately $2.0 billion to our stockholders in the form of divi
  • $73 million — 2024. ** Stock repurchases includes $73 million in connection with employee stock plans

Filing Documents

Executive Compensation

Executive Compensation 67 Certain Transactions with Management and Others 82 Audit Committee Report 83 Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm 85 Proposal Three: Non-Binding Advisory Vote with Respect to the Compensation of the Company's Named Executive Officers 86 Proposal Four: Approve Amendment to the Company's Restated Certificate of Incorporation to Limit the Liability of Certain Officers of the Company as Permitted by Delaware Law 87 Proposal Five: Approve Amendment to the Company's Restated Certificate of Incorporation to Eliminate Supermajority Voting Requirement in Connection with Certain Transactions 89 Proposal Six: Stockholder Proposal on Simple Majority Vote 91 Frequently Asked Questions 93 Incorporation by Reference 100 Additional Information 100 Annex I A-I-1 Annex II A-II-1 Annex III A-III-1 Table of Contents Proxy Summary General Information Meeting: 2024 Annual Meeting of Stockholders Place: www.virtualshareholdermeeting.com/HUM2024 Date: Thursday, April 18, 2024 Time: 1:00 p.m., Eastern Time Record Date: February 29, 2024 How to Vote Your Shares You may vote if you were a stockholder as of the close of business on February 29, 2024. Online www.proxyvote.com By Mail Complete, sign, date, and return your proxy card in the envelope provided By Phone Call the phone number located on the top of your proxy card During the Meeting Attend our virtual annual meeting and cast your vote using the webcast voting options Voting Overview Items of Business Board Recommendation Page Reference 1. Elect the eleven (11) director nominees named in the proxy statement. FOR 4 2. Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2024. FOR 85 3. Non-binding advisory vote to approve the compensation of the Company's Named Executive Offic

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.